Source: CureToday articles
Imdelltra improved survival and quality of life versus chemotherapy as second-line treatment for small cell lung cancer, reinforcing it as a new SOC.
Recent Content
- Targeted Screening Tools Can Increase Pneumococcal Vaccine Uptake in Health-System Retail Pharmacies
- Study Finds Vitamin D3 Supplementation Reduces Telomere Attrition
- Vadadustat and Darbepoetin Alfa Show Similar Safety, Efficacy in Patients With NDD-CKD and DD-CKD
- Being in the Present Moment With Multiple Myeloma
- Columvi Combo Enhances Survival Outcomes in R/R Lymphoma Subgroup
- Study: Maternal Asthma Increases Incidence of Adverse Perinatal Outcomes
- ASCO 2025: Insights on NALIRIFOX Use in Metastatic Pancreatic Ductal Adenocarcinoma From the NAPOLI-3 Trial
- Iopofosine-131 Earns FDA Breakthrough for Waldenstrom Macroglobulinemia
- Pharmacists Should Be Recommending Penicillin Allergy Testing
- Amid Measles Outbreak, CDC Advises International Travelers to Receive MMR Immunization